Richard Hajdu

Statistics

Publications

Citations

4.1K

H-Index

Active since

1982

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Richard Hajdu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1982–2016

Publications

Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

Suzanne Mandala, Richard Hajdu, James D. Bergstrom et al. · Science · 2002 · 1.7K citations

Life Sciences, Immunology, Pharmacology +17

Mice Deficient in Sphingosine Kinase 1 Are Rendered Lymphopenic by FTY720

María L. Allende, Teiji Sasaki, Hiromichi Kawai et al. · Journal of Biological Chemistry · 2004 · 445 citations · Full text

Life Sciences, Biochemistry, Cell Biology +15

Metabolism of Thienamycin and Related Carbapenem Antibiotics by the Renal Dipeptidase, Dehydropeptidase-I

H Kropp, Jon G. Sundelof, Richard Hajdu et al. · Antimicrobial Agents and Chemotherapy · 1982 · 340 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Immune Cell Regulation and Cardiovascular Effects of Sphingosine 1-Phosphate Receptor Agonists in Rodents Are Mediated via Distinct Receptor Subtypes

M J Forrest, S.-Y. Sun, Richard Hajdu et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 334 citations

Medicine, Pharmacology, Physiology +17

Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872)

Richard Hajdu, R Thompson, Jon G. Sundelof et al. · Antimicrobial Agents and Chemotherapy · 1997 · 167 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

1–5 of 29